Why a freeze-dried cake looks the way it doesWhat the studies show

The white solid in a vial is the skeleton left behind when ice was removed by sublimation. How it looks was decided by how the water froze.

5 min read · Mixed evidence · Updated November 2026

In short

Name
lyophilization
Evidence
Mixed evidence
Bottom line
Settled pharmaceutical engineering, with the process physics well described and an industry consensus on what cake appearance does and does not mean.

Before you read this

This guide explains what published studies found. That is all it is.

It is not medical advice and it is not instructions for using anything. Where a dose appears, we are reporting what a named study gave the people or animals in it — a fact about the study, not an instruction to you.

The compounds here are not approved by the FDA for use in people and are sold for laboratory research only. A study tells you what happened to the subjects in it; it does not tell you what would happen to you. Talk to a doctor first.

What it is

A freeze-dried cake is what remains after water is taken out of a frozen solution without ever letting it melt. The solution is frozen, the pressure in the chamber is dropped far below the vapour pressure of ice, and the ice turns straight to vapour, leaving a porous solid in the exact shape the ice crystals occupied. Freeze-drying is the standard way of making unstable molecules — vaccines, antibodies, peptides — storable at all, because water is the medium in which most of their degradation reactions run 1. The practical design of the process was laid out in a 2004 paper by Tang and Pikal that is still the reference in the field 2. The cake is a record of three steps: freezing, primary drying and secondary drying.

The rest of this guide is free

Unlock the Why a freeze-dried cake looks the way it does guide — and every other one

What the studies found, what they didn't, every source linked. Enter your email once; the link we send opens all of them on this device, plus one plain-language study breakdown a week.

Terms

These guides explain what published studies found. That is all they are. They are not medical advice, and they are not instructions for using anything. Nothing here is meant to diagnose, treat, cure or prevent any illness. The compounds discussed on this site are not approved by the FDA for use in people. Research compounds are sold for laboratory use only, not for use in humans or animals. A study tells you what happened to the people or animals in it. It does not tell you what would happen to you. What you do with what you read here is your responsibility, so talk to a doctor first. This site is published by Progression Labs, which sells research compounds.

Freezing sets the structure

Water in a vial on a cold shelf does not freeze at 0 °C. It supercools, typically to 10 or 20 degrees below zero, and then nucleates all at once; the deeper the supercooling, the more nuclei form and the smaller the ice crystals that grow from them 3. The solute — the peptide, and any buffer or bulking sugar — is excluded from the growing ice and concentrates into the channels between crystals, where it ends up as a glass or, for something like mannitol, as a crystalline matrix. The ice crystals become the pores of the cake, so fast freezing with deep supercooling gives a fine-pored, dense-looking cake, and slow freezing or a deliberate annealing step gives larger crystals and a coarser, more open one 3. Larger pores let vapour escape faster in the next step, which is why manufacturers try to control nucleation and why two vials of the same solution can look quite different.

Two kinds of drying

Primary drying removes the ice. The chamber is pumped down to a fraction of a millibar and the shelf is warmed just enough to supply the heat of sublimation while keeping the product below its collapse temperature — the point at which the freeze-concentrated glass between the pores softens and flows 4. Hold it below that and the pores keep their walls; let it rise above and the structure slumps, which is the collapse seen as a shrunken, glassy or partly melted-looking cake. Secondary drying follows: the ice is gone, but the solid still holds water bound to its surfaces, often several percent by weight, and the shelf is raised, sometimes well above room temperature, to drive it off over hours until residual moisture is typically below one or two percent 25. Both steps are run against sensors and clocks, not by eye.

Why cakes shrink and crack

Shrinkage happens because the dried glass takes up less volume than the frozen matrix it replaced, and the cake pulls away from the vial wall as it loses water; cracking happens when that shrinkage is uneven, or when the top skin dries first and the material underneath contracts beneath it. A small amount of solid in a large volume — a few milligrams of peptide with no bulking agent — gives a sparse, fragile cake that may sit as a thin disc or a loose powder rather than a plug, because there was never enough material to build a wall 5. These are mechanical facts about the solid, not about the molecule inside it.

Appearance is not a quality test

In 2017 a group of industry and academic scientists published a consensus review of cake appearance that asked exactly what such defects mean. Their conclusion was that cracking, shrinkage and a cake that has pulled from the wall are generally cosmetic and do not by themselves indicate a change in potency, moisture or how the solid dissolves, while gross collapse or melt-back can go with higher moisture and slower dissolution and is worth investigating — investigating, with an assay, not condemning on sight 5. The things that decide whether a freeze-dried peptide is what its label says — purity, identity, residual moisture, endotoxin — are measured, and none of them can be read from the shape of a white solid.

What these studies are, and aren't

Mixed evidence. Settled pharmaceutical engineering, with the process physics well described and an industry consensus on what cake appearance does and does not mean.

Sources

  1. 1Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharmaceutical Research, 1997.
  2. 2Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharmaceutical Research, 2004.
  3. 3Searles JA, Carpenter JF, Randolph TW. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. Journal of Pharmaceutical Sciences, 2001.
  4. 4Pikal MJ, Shah S. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase. International Journal of Pharmaceutics, 1990.
  5. 5Patel SM et al. Lyophilized Drug Product Cake Appearance: What Is Acceptable? Journal of Pharmaceutical Sciences, 2017.

More in How peptides work